Cross Country Healthcare stock had its Relative Strength (RS) Rating upgraded from 62 to 75 Thursday -- a welcome improvement, but still shy of the 80 or higher score you look for.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's proprietary rating identifies market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the last 52 weeks stacks up against all the other stocks in our database.
Decades of market research shows that the market's biggest winners tend to have an RS Rating north of 80 as they begin their largest price moves. See if Cross Country Healthcare stock can continue to rebound and clear that threshold.
See How IBD Helps You Make More Money In Stocks
Is Cross Country Healthcare Stock A Buy?
Cross Country Healthcare stock is currently trading below its 50-day and 200-day moving averages. While it's not currently an ideal time to buy shares, see if the stock goes on to establish and enter a buying range in heavy volume. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
The health care staffing company reported negative growth for both the top and bottom lines last quarter.
Cross Country Healthcare stock holds the No. 9 rank among its peers in the Commercial Services-Staffing industry group. Headhunter Group ADR and BGSF are also among the group's highest-rated stocks.
